Literature DB >> 15070903

Arachidonic acid released by phospholipase A(2) activation triggers Ca(2+)-dependent apoptosis through the mitochondrial pathway.

Daniele Penzo1, Valeria Petronilli, Alessia Angelin, Claudia Cusan, Raffaele Colonna, Luca Scorrano, Francesco Pagano, Maurizio Prato, Fabio Di Lisa, Paolo Bernardi.   

Abstract

We studied the effects of the divalent cation ionophore A23187 on apoptotic signaling in MH1C1 cells. Addition of A23187 caused a fast rise of cytosolic Ca(2+) ([Ca(2+)](c)), which returned close to the resting level within about 40 s. The [Ca(2+)](c) rise was immediately followed by phospholipid hydrolysis, which could be inhibited by aristolochic acid or by pretreatment with thapsigargin in Ca(2+)-free medium, indicating that the Ca(2+)-dependent cytosolic phospholipase A(2) (cPLA(2)) was involved. These early events were followed by opening of the mitochondrial permeability transition pore (PTP) and by apoptosis in about 30% of the cell population. In keeping with a cause-effect relationship between addition of A23187, activation of cPLA(2), PTP opening, and cell death, all events but the [Ca(2+)](c) rise were prevented by aristolochic acid. The number of cells killed by A23187 was doubled by treatment with 0.5 microm MK886 and 5 microm indomethacin, which inhibit arachidonic acid metabolism through the 5-lipoxygenase and cyclooxygenase pathway, respectively. Consistent with the key role of free arachidonic acid, its levels increased within minutes of treatment with A23187; the increase being more pronounced in the presence of MK886 plus indomethacin. Cell death was preceded by cytochrome c release and cleavage of caspase 9 and 3, but not of caspase 8. All these events were prevented by aristolochic acid and by the PTP inhibitor cyclosporin A. Thus, A23187 triggers the apoptotic cascade through the release of arachidonic acid by cPLA(2) in a process that is amplified when transformation of arachidonic acid into prostaglandins and leukotrienes is inhibited. These findings identify arachidonic acid as the causal link between A23187-dependent perturbation of Ca(2+) homeostasis and the effector mechanisms of cell death.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15070903     DOI: 10.1074/jbc.M310381200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

Review 1.  Membrane biophysics and mechanics in Alzheimer's disease.

Authors:  Xiaoguang Yang; Sholpan Askarova; James C-M Lee
Journal:  Mol Neurobiol       Date:  2010-05-01       Impact factor: 5.590

2.  Genetic ablation of calcium-independent phospholipase A(2)γ (iPLA(2)γ) attenuates calcium-induced opening of the mitochondrial permeability transition pore and resultant cytochrome c release.

Authors:  Sung Ho Moon; Christopher M Jenkins; Michael A Kiebish; Harold F Sims; David J Mancuso; Richard W Gross
Journal:  J Biol Chem       Date:  2012-07-09       Impact factor: 5.157

3.  Role of intracellular calcium and phospholipase A2 in arachidonic acid-induced toxicity in liver cells overexpressing CYP2E1.

Authors:  Andres A Caro; Arthur I Cederbaum
Journal:  Arch Biochem Biophys       Date:  2006-11-03       Impact factor: 4.013

4.  Adipocytokines leptin and adiponectin function as mast cell activity modulators.

Authors:  Paulina Żelechowska; Ewa Brzezińska-Błaszczyk; Magdalena Wiktorska; Sylwia Różalska; Sebastian Wawrocki; Elżbieta Kozłowska; Justyna Agier
Journal:  Immunology       Date:  2019-07-10       Impact factor: 7.397

5.  Calcium-independent phospholipase A2 localizes in and protects mitochondria during apoptotic induction by staurosporine.

Authors:  Konstantin Seleznev; Chunying Zhao; Xu Hannah Zhang; Keying Song; Zhongmin Alex Ma
Journal:  J Biol Chem       Date:  2006-05-25       Impact factor: 5.157

Review 6.  Mitochondria and cardioprotection.

Authors:  Fabio Di Lisa; Marcella Canton; Roberta Menabò; Nina Kaludercic; Paolo Bernardi
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

7.  Dietary supplementation with docosahexaenoic acid, but not eicosapentaenoic acid, dramatically alters cardiac mitochondrial phospholipid fatty acid composition and prevents permeability transition.

Authors:  Ramzi J Khairallah; Genevieve C Sparagna; Nishanth Khanna; Karen M O'Shea; Peter A Hecker; Tibor Kristian; Gary Fiskum; Christine Des Rosiers; Brian M Polster; William C Stanley
Journal:  Biochim Biophys Acta       Date:  2010-05-21

8.  Treatment with docosahexaenoic acid, but not eicosapentaenoic acid, delays Ca2+-induced mitochondria permeability transition in normal and hypertrophied myocardium.

Authors:  Ramzi J Khairallah; Karen M O'Shea; Bethany H Brown; Nishanth Khanna; Christine Des Rosiers; William C Stanley
Journal:  J Pharmacol Exp Ther       Date:  2010-07-12       Impact factor: 4.030

9.  Activation of mitochondrial ERK protects cancer cells from death through inhibition of the permeability transition.

Authors:  Andrea Rasola; Marco Sciacovelli; Federica Chiara; Boris Pantic; William S Brusilow; Paolo Bernardi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

10.  Serine hydrolase inhibitors block necrotic cell death by preventing calcium overload of the mitochondria and permeability transition pore formation.

Authors:  Bogeon Yun; HeeJung Lee; Moumita Ghosh; Benjamin F Cravatt; Ku-Lung Hsu; Joseph V Bonventre; Heather Ewing; Michael H Gelb; Christina C Leslie
Journal:  J Biol Chem       Date:  2013-12-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.